We observed that in both AML and B-ALL cell lines, FLT3 activates many of the similar signaling pathways, such as JAK-STAT pathway, RAS-MAPK pathway, and phospholipase C-gamma (Figure 3 and 4). The gene discussed is FLT3; the disease is acute lymphoblastic leukemia.